Latest News

IVERIC bio to Announce Zimura® 18 Month Data from the OPH2003 Phase 3 Clinical Trial in Geographic Atrophy Secondary to Age-Related Macular Degeneration and Host Conference Call on Monday, June 15, 2020




NEW YORK–(BUSINESS WIRE)–IVERIC announced that it will report 18 month data from the Zimura® Phase 3 clinical trial in geographic atrophy secondary to AMD on June 15, 2020.

Source link

Related posts

How Predictive #Analytics And Big Data In #Healthcare Can Improve Care via @Hea…

Newsemia

Next-Gen Artificial Pancreas Boosts Blood Sugar Control

Newsemia

Medical News Today: What to know about sleep aids

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World